Sage Revell

Sage Revell is a market leader in the life sciences and technology sectors. She advises on national and cross-border mergers and acquisitions, venture capital, private equity, and corporate reorganizations. Sage represents emerging-growth companies and the investors who support them from the start-up phase, through growth stages, and all the way through to exit.

Sage was listed in The Top 25 Biotechnology and Life Sciences Attorneys of 2024 by Attorney Intel, which recognizes legal professionals who combine leading sector experience with advanced academic backgrounds in the life sciences fields, which enables them to provide unparalleled guidance across numerous legal issues.

Sage speaks and writes extensively on matters in the life sciences and technology sectors and is an advocate for women's health and wellness. She is frequently invited to present globally on these topics, including at the LSX World Congress, UCSF Rosenman Institute California, Startup Boston, Imperial College London, and The Guildhall.

Prior to joining Jones Day, Sage advised, amongst others: a global leader in its investments in developing, manufacturing, and marketing products for life sciences research and clinical trials; a fertility focused platform for clinical workflow and patient management; a health tech company that is enhancing medical imaging using artificial intelligence for early detection of cancers; a pharma company in developing a portfolio of transformative biological and well-being products for women; and a clinical stage biotech company in the men's health space.

Sage also has worked with conservation and water purification technology companies; a regulatory technology company involving digital currencies and blockchain-based financial ecosystem; a marine data intelligence company improving vessel efficiency through machine learning; and a French company specializing in packaging solutions for medical devices.